Share-Based Awards (Tables)

9 Months Ended

Sep. 30, 2026

Share-Based Payment Arrangement [Abstract]

The following table summarizes option award activity for the nine months ended September 30, 2026:


	Number of Shares Subject to Existing Options (in thousands)	Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (in millions)
Outstanding at January 1, 2026	27,303	$	49.79	5.7	$	565
Granted	5,580	41.94
Exercised	(811)	28.93
Forfeited or canceled	(991)	52.95
Outstanding at September 30, 2026	31,081	48.82		5.7	—
Vested and exercisable at September 30, 2026	23,527	48.54		4.6	—

Schedule of Fair Value of Options Granted, Estimated at Date of Grant Using Black Scholes Merton Option Pricing Model

The following assumptions were used to determine the fair value of option awards granted for the periods presented:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2026	2025	2026	2025
Expected volatility	53%	54%	53% - 56%	54% - 60%
Risk-free interest rate	4.70%	3.82%	3.87% - 4.70%	3.82% - 4.17%
Weighted-average expected life	5.8 years	5.3 years	5.8 - 7.0 years	5.3 - 6.8 years
Weighted-average fair value of options granted	$18.90	$46.43	$22.69	$43.34

Schedule of Restricted Stock Units Activity

The following table summarizes activity for restricted stock units for the nine months ended September 30, 2026:


	Restricted Stock Units (in thousands)	Weighted-Average Grant Date Fair Value
Unvested outstanding at January 1, 2026	9,319	$	61.83
Granted	9,314	40.41
Vested	(4,000)	53.46
Forfeited	(1,655)	56.68
Unvested outstanding at September 30, 2026	12,978	$	49.70

Schedule of Effects of Share Based Compensation in Consolidated Statements of Operations

The following table presents the effects of share-based compensation expense in our condensed consolidated statements of operations during the periods presented (in millions):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Cost of revenue	$	2	$	3	$	6	$	9
Sales and marketing	13		18		43		55
Technology and development	33		41		97		119
General and administrative	26		37		84		112
Impairment and restructuring costs	12		—		25		—
Total share-based compensation	$	86	$	99	$	255	$	295